Oxford AstraZeneca seek Covid vaccine approval after ‘effective’ trials
British drugs group AstraZeneca and the University of Oxford have announced that they will seek regulatory approval for their coronavirus vaccine after “effective” trials involving 23,000 people.
https://s.rfi.fr/media/display/b6ecf998-f349-11ea-a19d-005056bff430/w:1024/p:16×9/2020-09-09T191944Z_726649049_RC27VI957VJR_RTRMADP_3_HEALTH-CORONAVIRUS-ASTRAZENECA.JPG
